missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system.
477.00€ - 1724.00€
Specifications
| Delivery Type | Lentiviral |
|---|---|
| Format | Tube |
| Control Type | Positive Control |
| RNAi Type | gRNA |
| Species | Human |
Alert:
For Research Use Only. Not for use in diagnostic procedures.
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
15697888
|
Invitrogen™
A32060 |
100 mL |
477.00€
100µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
15910383
|
Invitrogen™
A32830 |
1 mL |
1724.00€
1mL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%.
The Invitrogen™ LentiArray CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice. This construct also expresses emGFP to provide a visual readout of successful transduction that can be used in determining Multiplicity of Infection (MOI).
Specifications
| Lentiviral | |
| Positive Control | |
| Human | |
| LentiArray™ | |
| U6 |
| Tube | |
| gRNA | |
| Genome Editing | |
| gRNA | |
| Dry Ice |
For Research Use Only. Not for use in diagnostic procedures.